ID: ALA4213799

Max Phase: Preclinical

Molecular Formula: C23H30Cl2N4O4

Molecular Weight: 424.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1OC)C(C1CCc3nc(N4CCOCC4)[nH]c(=O)c3C1)=NCC2.Cl.Cl

Standard InChI:  InChI=1S/C23H28N4O4.2ClH/c1-29-19-12-14-5-6-24-21(16(14)13-20(19)30-2)15-3-4-18-17(11-15)22(28)26-23(25-18)27-7-9-31-10-8-27;;/h12-13,15H,3-11H2,1-2H3,(H,25,26,28);2*1H

Standard InChI Key:  FWZSBKHQWSMVQD-UHFFFAOYSA-N

Associated Targets(Human)

ROCK2 Tclin Rho-associated protein kinase 2 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Uterus (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 424.50Molecular Weight (Monoisotopic): 424.2111AlogP: 1.77#Rotatable Bonds: 4
Polar Surface Area: 89.04Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.00CX Basic pKa: 6.14CX LogP: 1.48CX LogD: 1.47
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.80Np Likeness Score: -0.42

References

1. Domokos D, Fülöp F, Falkay G, Gáspár R..  (2018)  Effects of newly synthetized isoquinoline derivatives on rat uterine contractility and ROCK II activity.,  28  (3): [PMID:29269216] [10.1016/j.bmcl.2017.12.017]

Source